Cradle is a biotech company that uses prediction algorithms and AI design recommendations to assist biologists in designing proteins. Cradle offers complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data.
cradle.bioThese are collections Cradle is a part of. Click on the collection name to view similar companies.
Series B
$73,000,000
Series A
$24,000,000
Seed
5,500,000 EUR
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Cradle.